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Objectives We sought to examine the association of early adulthood blood pressure with cardiovascular disease (CVD)
mortality, while accounting for middle-age hypertension.
Background Elevated blood pressure in middle age is an established CVD risk factor, but evidence for association with mea-
surements earlier in life is sparse.
Methods The HAHS (Harvard Alumni Health Study) is a cohort study of 18,881 male university students who had their
blood pressure measured at university entry (1914 to 1952; mean age 18.3 years) and who responded to a
questionnaire mailed in either 1962 or 1966 (mean age 45.8 years) in which physician-diagnosed hypertension
status was reported. Study members were subsequently followed for mortality until the end of 1998.
Results Following adjustment for age, body mass index, smoking, and physical activity at college entry, compared with
men who were normotensive according to the Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure criteria (120/80 mm Hg), there was an ele-
vated risk of coronary heart disease (CHD) mortality (1,917 deaths) in those who were pre-hypertensive (120 to
139/80 to 89 mm Hg) (hazard ratio [HR]: 1.21; 95% confidence interval [CI]: 1.07 to 1.36), stage 1 (140 to
159/90 to 99 mm Hg) (HR: 1.46; 95% CI: 1.25 to 1.70), and stage 2 hypertensive (160/100 mm Hg)
(HR: 1.89; 95% CI: 1.46 to 2.45), incremental across categories (ptrend  0.001). After additionally accounting
for middle-age hypertension, estimates were somewhat attenuated, but the pattern remained. Similar associa-
tions were apparent for total and CVD mortality, but not stroke mortality.
Conclusions Higher blood pressure in early adulthood was associated with elevated risk of all-cause mortality, CVD, and CHD,
but not stroke, several decades later. Effects largely persisted after taking into account mediation by middle-age
hypertension. Thus, the long-term benefits of blood pressure lowering in early adulthood are promising, but sup-
porting trial data are required. (J Am Coll Cardiol 2011;58:2396–403) © 2011 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.07.045In addition to cigarette smoking, raised blood cholesterol,
and diabetes, elevated blood pressure is a well-established
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accepted July 5, 2011.risk factor for developing CHD and stroke (1–4). Associ-
ations appear to be strong, independent of other risk factors,
and incremental across the full blood pressure range (3,4).
However, to date, findings have largely been confined to
middle-aged and older populations (5), limiting the under-
standing of the relationship, if any, with blood pressure
measured earlier in life. Like other physiological risk factors,
blood pressure measured in early adulthood “tracks” into
See page 2404
middle age, such that individuals who initially have higher
blood pressure also tend to have higher values in later life
(6). It is unknown whether any increased risk of chronic
disease apparently conferred by blood pressure in early
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November 29, 2011:2396–403 Life Course Blood Pressure and Mortalitylife is merely a function of such correlation, or whether
the effects are genuine. Disentangling this issue has
potentially important policy implications: if early adult-
hood blood pressure directly influences disease develop-
ment, then this may point to the need to implement
blood pressure–lowering interventions at an earlier stage
in life than is currently the case (7).
To date, a limited number of studies have examined
associations between early adulthood blood pressure and
long-term CHD or stroke (8–12). In a male student cohort,
blood pressure measured around age 20 years was associated
with risk of coronary heart disease (CHD) mortality up to
50 years later (9,12). Similar results have been reported in a
large study of Swedish men followed into middle age (10).
To our knowledge, the role of later blood pressure or
hypertension in explaining the early blood pressure–later
CHD relationship has yet to be examined.
In the HAHS (Harvard Alumni Health Study), blood
pressure and other risk factors were measured directly at
university entry, and study members reported physician-
diagnosed hypertension during middle-age. Extended mor-
tality surveillance of this cohort, therefore, provides an
opportunity to examine the direct impact of blood pressure
in early adulthood on the long-term risk of CHD and stroke
mortality.
Methods
The HAHS is an ongoing cohort study of the predictors of
chronic disease in males enrolling as undergraduates at
Harvard University, Boston, Massachusetts, between 1916
and 1950. In 1962 or 1966 (1962/1966), surviving alumni
were sent a health questionnaire on lifestyle and physician-
diagnosed diseases, including hypertension. There was a
68% questionnaire response, comprising 21,582 men (13),
among whom data from a physical examination at college
entry were available in 19,850 (92%). Data on 29 men were
discarded on the basis of data errors with recorded dates,
leaving 19,821 men. Of these, 18,881 (95%) had complete
data for systolic and diastolic blood pressure at college entry
and hypertension in 1962/1966, forming our analytical
sample.
Assessment of blood pressure and other covariates. Uni-
versity students underwent a standardized medical exami-
nation upon college entry when information on smoking
(14), blood pressure, height, and weight were measured
using standard protocols (15). Examinations were made by
1 of several physicians in the context of a conventional
doctor–patient relationship, with the case-taking results
itemized on standard forms (14). Physical activity was
ascertained from undergraduate athletic records (8). Body
mass index (BMI) in kg/m2 was calculated from measured
eight and height.
Questionnaires were mailed to surviving alumni in the
962/1966 survey when “middle-age” (mean age 45.8 years)
ypertension was ascertained from self-reports of physicianiagnosis. In an earlier validation
tudy, self-reported hypertension
as compared with directly mea-
ured blood pressure or treat-
ent for hypertension. Using
160 mm Hg systolic and 95
m Hg diastolic blood pressure
r a history of treatment for high
lood pressure as the criteria for
he definition of hypertension at
hat time, self-reports showed
0% sensitivity and 97% specific-
ty (16).
ortality ascertainment. The Harvard Alumni Office
aintains listings of deceased alumni and obtains copies of
fficial death certificates. Vital status and cause of death
ere determined from certificates available until the end of
998, with 99% completeness (17). Deaths were classified
s cardiovascular disease (CVD) for decedents with the
nternational Classification of Diseases (ICD) (Seventh
evision) codes (18) of 330 to 334 and 400 to 446 for the
rimary or underlying cause of death (19); CHD and stroke
eaths were identified by codes 420 and 330 to 334,
espectively.
tatistical analyses. In our analyses, we coded blood pres-
ure in 2 ways: 1) continuously (standard deviation change in
blood pressure); and 2) categorically according to the current
Seventh Report of the Joint National Committee on Pre-
vention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC-7) criteria (see Table 1 for cutoffs) and
for a stepwise 10 mm Hg increase in systolic blood pressure
(see Table 2 for cutoffs).
Means were derived for continuous measurements strat-
ified by blood pressure categories, and categorical variables
were tabulated by these categories. Association between
systolic and diastolic blood pressure measurements was
assessed by correlation. Having determined that the propor-
tional hazards assumption had not been violated, a series of
Cox regression models (20) were fitted for total, CVD,
CHD, and stroke mortality across JNC-VI categories.
Initially, models were adjusted for age, followed by addi-
tional adjustment for BMI, smoking status, and physical
activity. We then considered additional adjustment for
hypertension in middle age. As this involves the effect of
early adulthood blood pressure being estimated condition-
ally on hypertension in middle age—conceivably on the
causal pathway of early adulthood blood pressure and
mortality—joint modeling was additionally used to explic-
itly estimate these inter-relationships (21). We examined
the impact of competing risks analyses for cause-specific
mortality. Finally, because study entry covered a broad range
of years (1914 to 1952), study members recruited earlier
would have had reduced access to antihypertensive thera-
pies. We therefore examined to what extent year of mea-
surement modified the association of blood pressure with
Abbreviations
and Acronyms
BMI  body mass index
CHD  coronary heart
disease
CVD  cardiovascular
disease
JNC  Joint National
Committee on Prevention,
Detection, Evaluation, and
Treatment of High Blood
PressureCVD.
HR (95% CI) for the Relation of Blood Pressure in Early and Mid-Adulthood With All-Cause and CVD Mortality (N  18,881)—HAHSTable 1 HR (95% CI) for the Relation of Blood Pressure in Early and Mid-Adulthood With All-Cause and CVD Mortality (N  18,881)—HAHS
n
All-Cause CVD
Deaths Age-Adjusted
Age- and University
Covariate-Adjusted*
Age-, University Covariate-,
and 62/66 Hypertension-
Adjusted* Deaths‡ Age-Adjusted
Age- and University
Covariate-Adjusted*
Age-, University Covariate-,
and 62/66 Hypertension-
Adjusted*
University entry (18.4 yrs)
Per SD (13.1 mm Hg) increase in
systolic blood pressure
18,881 7,972 1.05 (1.03–1.07) 1.05 (1.03–1.08) 1.03 (1.01–1.06) 3,343 1.09 (1.05–1.13) 1.08 (1.04–1.12) 1.04 (1.01–1.09)
Categories of systolic blood pressure, mm Hg
105 1,762 728 0.97 (0.89–1.05) 0.99 (0.89–1.09) 0.99 (0.89–1.09) 283 0.95 (0.82–1.09) 0.98 (0.84–1.14) 0.97 (0.83–1.14)
105–114 4,436 1,768 1.00 (ref) 1.00 (ref) 1.00 (ref) 698 1.00 (ref) 1.00 (ref) 1.00 (ref)
115–124 6,491 2,716 1.03 (0.97–1.10) 1.04 (0.97–1.12) 1.03 (0.96–1.10) 1,153 1.11 (1.01–1.22) 1.09 (0.98–1.21) 1.06 (0.96–1.18)
125–134 3,796 1,582 1.01 (0.94–1.08) 1.04 (0.96–1.12) 1.02 (0.94–1.10) 675 1.09 (0.98–1.21) 1.09 (0.97–1.23) 1.05 (0.93–1.18)
135–144 1,707 822 1.17 (1.08–1.27) 1.16 (1.05–1.27) 1.11 (1.01–1.21) 370 1.33 (1.17–1.51) 1.28 (1.11–1.47) 1.18 (1.03–1.36)
145–154 470 242 1.23 (1.07–1.40) 1.24 (1.07–1.43) 1.16 (1.00–1.34) 112 1.43 (1.17–1.75) 1.47 (1.18–1.81) 1.29 (1.04–1.60)
155 219 114 1.23 (1.02–1.49) 1.32 (1.08–1.63) 1.18 (0.96–1.45) 52 1.41 (1.07–1.87) 1.43 (1.04–1.95) 1.15 (0.84–1.58)
p Value for trend 18,881 7,972 0.001 0.001 0.006 3,343 0.001 0.001 0.003
Normal† 6,748 2,531 1.00 (ref) 1.00 (ref) 1.00 (ref) 992 1.00 (ref) 1.00 (ref) 1.00 (ref)
Pre-hypertensive† 9,577 4,013 1.04 (0.99–1.09) 1.05 (0.99–1.11) 1.03 (0.97–1.09) 1,384 1.12 (1.03–1.21) 1.13 (1.04–1.24) 1.09 (1.00–1.20)
Stage 1 hypertension† 2,176 1,176 1.12 (1.05–1.20) 1.14 (1.06–1.24) 1.09 (1.01–1.18) 530 1.27 (1.14–1.41) 1.28 (1.14–1.44) 1.17 (1.04–1.31)
Stage 2 hypertension† 380 252 1.26 (1.11–1.44) 1.28 (1.11–1.48) 1.19 (1.03–1.37) 122 1.53 (1.27–1.85) 1.51 (1.23–1.86) 1.31 (1.06–1.61)
p Value for trend 18,881 7,972 0.001 0.001 0.001 3,028 0.001 0.001 0.001
Middle-age (44.4 yrs)
Nonhypertensive 17,007 6,745 1.00 (ref) 2,704 1.00 (ref)
Hypertensive 1,874 1,227 1.57 (1.48–1.67) 639 2.02 (1.85–2.20)
Values are n or hazard ratio (95% confidence interval). Model 1: adjusted by age at college entry; Model 2: adjusted by age, BMI, cigarette smoking status, and physical activity at college entry; Model 3: Adjusted by age, BMI, cigarette smoking status, and physical activity
at college entry, and hypertension in 1962/1966; *n 15,488 due to missing BMI, physical activity, and smoking status data; †Current Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria categories: normotensive
(120/80mmHg), pre-hypertension (120–139/80–89mmHg), stage 1 hypertension (140–159/90–99mmHg), and stage 2 hypertension (160/100mmHg). ‡The remainder of the CVD deaths (n 846; 25%) were chieflymyocardial degeneration with atherosclerosis
(International Classification of Diseases Seventh Revision [ICD 7] code 422.1; n  203), other and unspecified diseases of heart (ICD 7 code 434; n  167), and aortic aneurysm (ICD 7 code 451; n  105).
BMI  body mass index; CI  confidence interval; CVD  cardiovascular disease; HAHS  Harvard Alumni Health Study; HR  hazard ratio; ref  reference.
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November 29, 2011:2396–403 Life Course Blood Pressure and MortalityTo account for missing data—affecting at least 1 item for
4,333 (18%) men—we used multiple imputation with 18
imputed datasets (corresponding to the percentage with
missing data) (22) among 19,821 men with a physical
examination record at university entry and health question-
naire, with valid dates of examination and death, if appli-
cable. Results with these imputed data were very similar to
the presented data (results not shown). All analyses were
performed in Stata/IC 10.1 (StatCorp, College Station,
Texas).
Results
In Table 1, we present the study characteristics according to
JNC-VI blood pressure categories at university entry (mean
age: 18.3 years). Smoking prevalence decreased with in-
creasing hypertension severity, but otherwise, there was no
relation between blood pressure and other variables at
university entry (Table 1). Self-reported hypertension in
middle age was associated with systolic and diastolic blood
pressure at university entry, with 63% and 50% increased
risk for standard deviation increases of 12.7 mm Hg
(systolic) and 9.9 mm Hg (diastolic), respectively. Systolic
and diastolic blood pressure measurements were reasonably
correlated (  0.40; p  0.001).
All-cause mortality. In Tables 2 and 3, we present hazard
ratios for the relation of blood pressure at university entry
with the 4 mortality outcomes (1,063,280 person-years of
follow-up; median: 56.3 years). In analyses of all-cause
mortality adjusted for age and other covariates at university
entry, there was a dose-response relationship across the
JNC-VI classification groups (p  0.001) (Table 1). Stan-
dard deviation increases in systolic blood pressure were
associated with a 5% increase in risk of death from any cause
Characteristics of Study Participants According to Blood PressureTable 2 Characteristics of Study Participants According to Blo
Normal
(n  6,748)
P
Hypert
(n  9
University entry (1914–1952)
Age, yrs 18.3 1.7 18.4
Systolic blood pressure, mm Hg 108.6 6.7 123.4
Diastolic blood pressure, mm Hg 66.9 6.8 74.9
BMI, kg/m2* 21.4 2.4 21.8
Physical activity 1 h/week† 2.4 (158) 3.4
1 to 4 h/week 31.3 (2,021) 30.3
5 h/week 30.3 (1,958) 31.1
Unknown hours 27.4 (1,765) 27.4
Varsity athletics 8.5 (551) 7.8
Current smoker‡ 37.6 (2,122) 34.0
Middle-age (1962 or 1966)
Age, yrs 44.4 8.4 45.7
Hypertensive 5.5 (371) 10.1
Values are mean SD or n (%). *BMI missing for 168men. †Physical activity information missing f
Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) criteria categories: normoten
to 159/90 to 99 mm Hg), and stage 2 hypertension (160/100 mm Hg).
Abbreviations as in Table 1.in both age-adjusted and university covariate-adjusted anal-
yses. These increased risks of death were slightly attenuated
but persisted even after adjustment for hypertension in
middle age. After adjusting for age, hypertension in middle
age was associated with an increased risk of total mortality
of 57%.
CVD mortality. Compared with all-cause mortality, CVD
mortality was more strongly associated with university blood
pressure (Table 2, Fig. 1). After adjusting for age- and other
university entry variables, dose-response associations were
evident across the 4 JNC-VI categories (p  0.001). These
gradients were attenuated but remained significant follow-
ing adjustment for hypertension in middle age. A 1-SD
elevation in systolic blood pressure was associated with a
significant 8% to 9% increase in risk of CVD death, which
was reduced to 4% on further adjustment for hypertension
in middle age. Hypertension status in middle age was
associated with a 2-fold increased risk of CVD.
CHD mortality. The effect of blood pressure and hyper-
tension status were more pronounced for CHD than CVD
mortality (Table 3). Compared with normotensive men,
pre-hypertensive men had 20%, stage 1 hypertensive men
43%, and stage 2 hypertensive men 93% elevated risks of
CHD mortality after adjustment for all university entry
covariates. The results were attenuated after additional
control for hypertension status in middle age, but many
remained significant. A 1-SD increase in systolic blood
pressure was associated with 14% to 15% increased risk,
largely persisting on adjustment for hypertension in middle
age. A doubling of risk of CHD mortality was experienced
by those with a diagnosis of hypertension by middle age.
Stroke mortality. There was no evidence of an association
between blood pressure at university entry and stroke
iversity Entry (N  18,881)—HAHSessure at University Entry (N  18,881)—HAHS
rsity Entry JNC-7 Blood Pressure Category§
Stage 1
Hypertension
(n  2,176)
Stage 2
Hypertension
(n  380)
Total
(N  18,881)
18.5 2.0 18.4 1.8 18.4 1.8
136.5 11.0 147.9 17.1 120.1 12.7
83.1 10.0 94.1 16.3 73.4 9.9
22.0 2.7 21.9 2.9 21.7 2.5
3.5 (73) 5.2 (19) 3.1 (566)
) 25.9 (547) 27.9 (102) 30.1 (5,450)
) 33.1 (697) 27.9 (102) 31.0 (5,618)
) 30.6 (646) 35.2 (129) 27.9 (5,056)
6.9 (145) 3.8 (14) 7.9 (1,425)
) 29.7 (562) 22.5 (76) 34.5 (5,532)
49.5 10.1 52.9 9.5 45.8 9.3
19.3 (421) 30.0 (114) 9.9 (1,874)
men. ‡Smoking status unknown for 2,853men. §Current Joint National Committee on Prevention,
120/80 mm Hg), pre-hypertension (120 to 139/80 to 89 mm Hg), stage 1 hypertension (140at Unod Pr
Unive
re-
ensive
,577)
 1.8
 7.2
 7.6
 2.5
(316)
(2,780
(2,861
(2,516
(715)
(2,772
 9.3
(968)
or 766
sive (
HR (95% CI) for the Relation of Blood Pressure in Early and Mid-Adulthood With CHD and Stroke Mortality (N  18,881)—HAHSTable 3 HR (95% CI) for the Relation of Blood Pressure in Early and Mid-Adulthood With CHD and Stroke Mortality (N  18,881)—HAHS
n
CHD Stroke
Deaths Age-Adjusted
Age- and University
Covariate-Adjusted*
Age-, University Covariate-,
and Hypertension-Adjusted* Deaths Age-Adjusted
Age- and University
Covariate-Adjusted*
Age-, University Covariate-,
and Hypertension-Adjusted*
University entry (18.4 yrs)
Per SD (13.1 mm Hg) increase in
systolic blood pressure
18,881 1,917 1.15 (1.10–1.20) 1.14 (1.09–1.20) 1.10 (1.05–1.16) 580 1.01 (0.93–1.09) 1.00 (0.91–1.10) 0.96 (0.88–1.05)
Categories of systolic blood pressure, mm Hg
105 1,762 148 0.94 (0.78–1.14) 0.93 (0.75–1.16) 0.93 (0.75–1.15) 56 0.96 (0.70–1.31) 0.95 (0.67–1.34) 0.94 (0.67–1.34)
105–114 4,436 370 1.00 (ref) 1.00 (ref) 1.00 (ref) 134 1.00 (ref) 1.00 (ref) 1.00 (ref)
115–124 6,491 672 1.22 (1.08–1.39) 1.17 (1.01–1.34) 1.14 (0.99–1.31) 194 0.96 (0.77–1.19) 0.93 (0.73–1.18) 0.90 (0.71–1.15)
125–134 3,796 390 1.20 (1.04–1.38) 1.16 (0.99–1.36) 1.12 (0.96–1.32) 111 0.92 (0.71–1.18) 0.82 (0.62–1.09) 0.79 (0.59–1.04)
135–144 1,707 235 1.61 (1.37–1.90) 1.54 (1.29–1.85) 1.43 (1.19–1.71) 59 1.08 (0.80–1.47) 0.98 (0.70–1.38) 0.90 (0.64–1.27)
145–154 470 69 1.68 (1.30–2.18) 1.67 (1.27–2.21) 1.48 (1.12–1.95) 19 1.23 (0.76–1.99) 1.27 (0.77–2.10) 1.11 (0.67–1.83)
155 219 33 1.72 (1.20–2.46) 1.68 (1.13–2.50) 1.36 (0.91–2.03) 7 0.99 (0.45–2.05) 1.13 (0.53–2.44) 0.88 (0.41–1.91)
p Value for trend 18,881 1,917 0.001 0.001 0.001 580 0.630 0.898 0.510
Normal† 6,748 542 1.00 (ref) 1.00 (ref) 1.00 (ref) 180 1.00 (ref) 1.00 (ref) 1.00 (ref)
Pre-hypertensive† 9,577 980 1.20 (1.08–1.33) 1.21 (1.07–1.36) 1.17 (1.03–1.32) 278 0.98 (0.81–1.18) 0.99 (0.80–1.22) 0.95 (0.76–1.17)
Stage 1 hypertension† 2,176 315 1.43 (1.25–1.65) 1.46 (1.25–1.70) 1.33 (1.14–1.56) 104 1.27 (1.00–1.62) 1.28 (0.98–1.67) 1.16 (0.88–1.52)
Stage 2 hypertension† 380 80 1.93 (1.53–2.45) 1.89 (1.46–2.45) 1.63 (1.26–2.12) 18 1.12 (0.69–1.83) 1.28 (0.78–2.09) 1.09 (0.66–1.79)
p Value for trend 18,881 1,917 0.001 0.001 0.001 580 0.122 0.082 0.372
Middle-age (44.4 yrs)
Nonhypertensive 17,007 1,550 1.00 (ref) 459 1.00 (ref)
Hypertensive 1,874 367 2.06 (1.76–2.27) 121 2.18 (1.65–2.58)
Values are n or hazard ratio (95% confidence interval). Model 1: adjusted by age at college entry; Model 2: adjusted by age, BMI, cigarette smoking status. and physical activity at college entry; Model 3: adjusted by age, BMI, cigarette smoking status, and physical activity
at college entry and hypertension in 1962/1966. *n  15,488 due to missing BMI, physical activity, and smoking status data. †Current Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria categories: normotensive
(120/80 mm Hg), pre-hypertension (120–139/80–89 mm Hg), stage 1 hypertension (140–159/90–99 mm Hg), and stage 2 hypertension (160/100 mm Hg).
CHD  coronary heart disease; other abbreviations as in Table 1.
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November 29, 2011:2396–403 Life Course Blood Pressure and Mortalitymortality (Table 3). Those with hypertension in middle age
had more than double the subsequent risk of stroke mor-
tality. For the 25% of CVD deaths due to causes other than
stroke and CHD, blood pressure associations were nonsig-
nificant (data not shown).
Results for diastolic blood pressure were similar to those
for systolic blood pressure throughout. When we repeated
analyses using more discrete groupings of blood pressure,
the results were essentially unchanged (Tables 2 and 3).
Results herein concurred with joint models (data not
shown). Additional adjustment for height as a proxy for
early-life socioeconomic position did not impact our results.
In re-analyses of all models confined to the subset of
participants with no missing covariate data (n  15,488),
results were consistent with those presented. Competing
risks analyses produced similar results to those presented in
Tables 2 and 3, indicating deaths from alternative causes did
not materially impact on findings. Finally, there was no
interaction (p  0.84) between blood pressure and CVD
according to year of study entry.
Discussion
In this large cohort of men with long-term follow-up,
higher blood pressure in early adulthood was associated with
elevated risks of CVD mortality and CHD mortality several
decades later, effects that remained after accounting for
hypertension in middle age.
Comparison with other studies. Four decades ago, a
report based on a nested case-control study within the
Figure 1 Survival Curves for CVD Mortality by Blood Pressure C
Numbers at risk: start of follow-up: 18,881; Year 20: 18,868; Year 40: 18,027; Ypresent cohort identified systolic blood pressure levels ofover 130 mm Hg to be associated with a 40% increased risk
of CHD death (8). In an era before statistical computing, it
was not possible to examine the role of confounding factors,
and the number of events was considerably lower than in the
present analyses. Additionally, there were insufficient deaths
to facilitate an examination of the extent to which the
development of hypertension at middle adulthood affects
the association between early adult blood pressure and
future CVD.
There are few comparable studies by which to consider
our results, especially given our median follow-up of almost
60 years in this cohort. Among men who were students at
Glasgow University during 1948 to 1968, a 10-mm Hg
increase in systolic blood pressure measured at around age
20 years was associated with a 15% increased risk of CHD
mortality (12), which remained following multivariable
adjustment (9). More recently, blood pressure in late ado-
lescence was positively associated with early incidence of
CHD and stroke in a large cohort of Swedish men (10).
Compared with those of McCarron et al. (9,12), the
association between blood pressure and all-cause, CVD and
CHD mortality were generally weaker but statistically more
robust in the present analyses, possibly due to our much
larger number of events (Table 4). Our findings were in
accord with those of Miura et al. (11), whose analyses were
based on an older population at baseline (maximum age of
study members was 39 years). None of these studies ac-
counted for the impact of later adulthood blood pressure on
the association between early blood pressure and subsequent
ories at College Entry (Mean Age 18.4 Years)
: 6,207; Year 80: 48. CVD  cardiovascular disease.ateg
ear 60CVD. However, 1 study did find that pre-hypertension
b tension
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of CHD—coronary calcification—after adjusting for sub-
sequent hypertension in middle age (23).
The lack of an association between university blood
pressure and total stroke mortality is surprising. Compared
with those of McCarron et al. (12), associations for JNC-VI
groupings were generally of low magnitude but similarly
statistically nonsignificant. The weaker association for
stroke versus CHD mortality may reflect blood pressure–
related atherosclerosis taking place earlier in adulthood
compared with the antecedents of stroke. There has been a
suggestion of a stronger association of blood pressure with
hemorrhagic compared with ischemic stroke (10), but we
lacked the resolution to differentiate by stroke subtype.
Study strengths and limitations. This study takes advan-
tage of its large sample size and number of outcomes, and is,
to our knowledge, the first to examine the potential medi-
ating role of middle-aged hypertension. This study is not, of
course, without shortcomings. First, confined to a popula-
tion of male university alumni, the representativeness of
these data in terms of sex, ethnicity (subjects are primarily
white), social class, and lifestyle (this cohort has a relatively
low smoking prevalence, which would explain the fewer
cardiovascular deaths compared with U.S. mortality statis-
tics [24]) is uncertain. It is possible that the association
between blood pressure and mortality may differ by sex,
social strata, and ethnicity, but we were unable to explore
these potential differences. Second, since these analyses are
confined to those responding to the mailed questionnaire in
1962/1966, they may be subject to certain errors such as
survivor or participation biases. For instance, respondents at
1962/1966 had lower BMI at time of university entry than
the nonrespondents, although the 2 groups did not differ
markedly in other hypertension- and CVD-related charac-
teristics (25). Third, information on blood pressure in
middle age is restricted to the dichotomous measure of
self-reported, physician-diagnosed hypertension (16), and
some random misclassification would be expected, poten-
tially producing residual confounding of the relationship
Comparisons of HR (95% CI) for the Relation of Blood Pressure PaAdulthood With CHD Mortality: Our Resul s in Relation to PreviousTable 4 C mparisons of HR (95% CI) f r the Relation of BloodAdulthood With CHD Mortality: Our Results in Relation
JNC-6 Classification
HAHS (Unadjusted)
University of Glasgow
(Unadjusted
No. of Deaths HR (95% Cl) No. of Deaths HR
Optimal 573 1.00 (ref) 11 1.00 (
Normal 698 1.19 (1.06–1.33) 44 1.19 (
Borderline 348 1.26 (1.11–1.44) 81 1.65 (
Stage 1 hypertension 336 1.45 (1.27–1.66) 79 1.66 (
Stage 2 hypertension 68 1.67 (1.30–2.14) 16 2.73 (
Stage 3 hypertension 17 4.22 (2.61–6.84) 3 2.91 (
p Value for trend 0.001
*Adjusted by age, BMI, cigarette smoking status, and physical activity at college entry. †Adjusted b
education. ‡Previous Joint National Committee on Prevention, Detection, Evaluation, and Treatment o
orderline (130–139/85–89 mmHg), stage 1 hypertension (140–159/90–99 mm Hg), stage 2 hyper
NA  not available; other abbreviations as in Tables 1 and 3.between early adulthood blood pressure and mortality inlater life. However, although the broader hypertension
range in middle age is not being fully captured, at the time
of the 1962/1966 questionnaire, a blood pressure measure-
ment of 160/95 mm Hg was the clinical threshold for
hypertension. Further, this study population consisted of
high socioeconomic status men who would be more likely to
exhibit and afford healthcare-seeking behavior (26). Indeed,
our data on hypertension have been shown to have high
sensitivity and specificity (16), thereby minimizing any
potential impact of misclassification. Finally, we lacked a
measurement of blood cholesterol level at university entry,
and were thus unable to assess potential confounding by this
(27) and other coronary risk factors such as parental history
of CHD and diet.
Conclusions
In this cohort, higher measured blood pressure in early
adulthood was associated with an elevated risk of total,
CVD, and CHD mortality several decades later, which
appeared to persist even after accounting for self-reported
hypertension in middle age. These results lend weight to
blood pressure–lowering strategies beginning earlier in the
life course than is currently the case. However, there is a lack
of clinical trial data to assess the efficacy and potential harm
of such intervention.
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